We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.16%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEVA
1001
Aeva Technologies
AEVA
$1.26B
$467K 0.01%
74,774
+2,817
+4% +$16.1K
NIO icon
1002
NIO
NIO
$12.1B
$464K 0.01%
47,933
+1,000
+2% +$8.46K
PWV icon
1003
Invesco Large Cap Value ETF
PWV
$1.71B
$463K 0.01%
9,930
-394
-4% -$17.9K
FLTR icon
1004
VanEck IG Floating Rate ETF
FLTR
$2.97B
$461K 0.01%
18,277
-1,625
-8% -$40.7K
CCD
1005
Calamos Dynamic Convertible & Income Fund
CCD
$721M
$460K 0.01%
21,163
+10,740
+103% +$240K
SLG icon
1006
SL Green Realty
SLG
$3.84B
$458K 0.01%
15,248
+2,037
+15% +$49.2K
IYH icon
1007
iShares US Healthcare ETF
IYH
$3.44B
$456K 0.01%
8,130
-10
-0.1% -$556
LAC
1008
DELISTED
Lithium Americas Corp. Common Shares
LAC
$452K 0.01%
22,361
+750
+3% +$15.5K
FN icon
1009
Fabrinet
FN
$16.3B
$451K 0.01%
3,470
-19
-0.5% -$2.03K
MOS icon
1010
The Mosaic Company
MOS
$6.93B
$450K 0.01%
12,844
-6,342
-33% -$245K
CSQ icon
1011
Calamos Strategic Total Return Fund
CSQ
$3.28B
$449K 0.01%
30,419
+12,504
+70% +$174K
FXO icon
1012
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$448K 0.01%
11,883
-26,946
-69% -$992K
ASGI
1013
abrdn Global Infrastructure Income Fund
ASGI
$756M
$448K 0.01%
25,173
+2,844
+13% +$50.2K
DBMF icon
1014
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.09B
$447K 0.01%
16,183
-819
-5% -$21.9K
CORT icon
1015
Corcept Therapeutics
CORT
$12.3B
$445K 0.01%
20,000
WPM icon
1016
Wheaton Precious Metals
WPM
$50.4B
$445K 0.01%
10,296
+188
+2% +$8.93K
TBLD
1017
Thornburg Income Builder Opportunities Trust
TBLD
$708M
$444K 0.01%
29,150
+11,900
+69% +$182K
CC icon
1018
Chemours
CC
$2.54B
$444K 0.01%
12,026
-1,427
-11% -$43.6K
RH icon
1019
RH
RH
$3.22B
$443K 0.01%
1,345
-120
-8% -$31.4K
GIB icon
1020
CGI
GIB
$15.2B
$443K 0.01%
4,203
+822
+24% +$83.7K
AIF
1021
DELISTED
Apollo Tactical Income Fund Inc.
AIF
$442K 0.01%
34,800
BTO
1022
John Hancock Financial Opportunities Fund
BTO
$806M
$441K 0.01%
16,460
+7,513
+84% +$203K
SLP icon
1023
Simulations Plus
SLP
$371M
$441K 0.01%
10,176
-431
-4% -$18.8K
ADMA icon
1024
ADMA Biologics
ADMA
$2B
$441K 0.01%
119,390
-6,500
-5% -$24.1K
ISTB icon
1025
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.12B
$439K 0.01%
9,419
-103
-1% -$4.84K

Similar funds

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.